Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized In-Human [13C]Pyruvate MRI in Healthy Volunteers
NCT05041166Phase 1Enrolling by invitation
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2021
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [1-13C]pyruvate (2 cohorts), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Signal-to-noise ratio at 1 day. Started Sep 2021; status: enrolling by invitation.
02
Drugs
[1-13C]pyruvate
Beyond the preview
Go deeper on NCT05041166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05041166.